Nociplastic Pain
12
5
5
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (12)
Effects of Aerobic and Strength Exercice on Nociplastic Pain in Temporomandibular Disorders
Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis
USG-Guided Shoulder Injections in Frozen Shoulder
Vestibular Innovation in Pain 2
Pain Reprocessing Therapy for Chronic Primary Pain
Efficacy of Home-delivered Transcranial Direct Electrical Stimulation or Chronic Pain
Central Sensitization and Nociplastic Pain in Pes Planus
Internet-Delivered Psychological Treatments for Chronic Pain in Adolescents: ACT and Pain Education.
Multimodal Imaging and Biospecimen Collection for Low Back Pain (LBPB)
Reliability and Validity of the IASP Clinical Criteria for Identifying Patients with Nociplastic Pain
Different Treatments in Chronic Pain Patients.
Prognostic Factor Research of Sensory Profiles in Development of Central Sensitization